Yunnan Meng Sheng Pharmaceutical Company Limited 
Yunnan Meng Sheng Pharmaceutical Company Limited was incorporated in Kuming. Yunnan in June, 2001 and is a sino-foreign equity joint venture. Meng Sheng is engaged in the business of research & development, manufacture and sale of pharmaceutical products in the PRC. The flagship products of Meng Sheng, Cerebroprotein Hydrolysate Injection and Ribonuclecl Acid for Injection can be used to enhance the growth of brain nerve cells and the recovery of brain functions. The feedback of the market has been positive since the launch of these products. The company will continue to enhance the research & development of its products and uplift its operational management capability to cope with the ever increasing market competition.

Shenzhen Xinpeng Biotechnology Company Limited
Shenzhen Xinpeng Biotechnology Company Limited concentrates on the research & development, manufacturing and sale of biotech products in the PRC. Xian Pang Biotech has two major products; they are Recombinant Human Granulocyte Colony Stimulating Factor Injection (rhG-CSF) and Recombinant Human Erythropoietin Injection (rhEPO). G-CSF is the key medicine for patients to prevent neutropenia and reduce the chance of having infection after chemotherapy. EPO is used to make red blood cell growth rapidly for anaemia patient due to chronic renal failure, multiple myeloma, myelodysplasia syndrome and AIDS. Our experienced management in engineering will continuously explore new products and control the production cost in order to increase competitiveness of our products and company in the market.